001     136770
005     20240229105057.0
024 7 _ |a 10.1002/ijc.31367
|2 doi
024 7 _ |a pmid:29524225
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:34237644
|2 altmetric
037 _ _ |a DKFZ-2018-01208
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Naudin, Sabine
|0 0000-0003-1049-6225
|b 0
245 _ _ |a Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study.
260 _ _ |a Bognor Regis
|c 2018
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1536312720_14253
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Recent evidence suggested a weak relationship between alcohol consumption and pancreatic cancer (PC) risk. In our study, the association between lifetime and baseline alcohol intakes and the risk of PC was evaluated, including the type of alcoholic beverages and potential interaction with smoking. Within the European Prospective Investigation into Cancer and Nutrition (EPIC) study, 1,283 incident PC (57% women) were diagnosed from 476,106 cancer-free participants, followed up for 14 years. Amounts of lifetime and baseline alcohol were estimated through lifestyle and dietary questionnaires, respectively. Cox proportional hazard models with age as primary time variable were used to estimate PC hazard ratios (HR) and their 95% confidence interval (CI). Alcohol intake was positively associated with PC risk in men. Associations were mainly driven by extreme alcohol levels, with HRs comparing heavy drinkers (>60 g/day) to the reference category (0.1-4.9 g/day) equal to 1.77 (95% CI: 1.06, 2.95) and 1.63 (95% CI: 1.16, 2.29) for lifetime and baseline alcohol, respectively. Baseline alcohol intakes from beer (>40 g/day) and spirits/liquors (>10 g/day) showed HRs equal to 1.58 (95% CI: 1.07, 2.34) and 1.41 (95% CI: 1.03, 1.94), respectively, compared to the reference category (0.1-2.9 g/day). In women, HR estimates did not reach statistically significance. The alcohol and PC risk association was not modified by smoking status. Findings from a large prospective study suggest that baseline and lifetime alcohol intakes were positively associated with PC risk, with more apparent risk estimates for beer and spirits/liquors than wine intake.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Li, Kuanrong
|b 1
700 1 _ |a Jaouen, Tristan
|b 2
700 1 _ |a Assi, Nada
|b 3
700 1 _ |a Kyrø, Cecilie
|0 0000-0002-9083-8960
|b 4
700 1 _ |a Tjønneland, Anne
|b 5
700 1 _ |a Overvad, Kim
|b 6
700 1 _ |a Boutron-Ruault, Marie-Christine
|b 7
700 1 _ |a Rebours, Vinciane
|b 8
700 1 _ |a Védié, Anne-Laure
|b 9
700 1 _ |a Boeing, Heiner
|b 10
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 11
|u dkfz
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 12
|u dkfz
700 1 _ |a Bamia, Christina
|b 13
700 1 _ |a Naska, Androniki
|b 14
700 1 _ |a Trichopoulou, Antonia
|b 15
700 1 _ |a Berrino, Franco
|b 16
700 1 _ |a Tagliabue, Giovanna
|b 17
700 1 _ |a Palli, Domenico
|0 0000-0002-5558-2437
|b 18
700 1 _ |a Panico, Salvatore
|b 19
700 1 _ |a Tumino, Rosario
|b 20
700 1 _ |a Sacerdote, Carlotta
|0 0000-0002-8008-5096
|b 21
700 1 _ |a Peeters, Petra H
|b 22
700 1 _ |a Bueno-de-Mesquita, H B As
|b 23
700 1 _ |a Weiderpass, Elisabete
|b 24
700 1 _ |a Gram, Inger Torhild
|b 25
700 1 _ |a Skeie, Guri
|b 26
700 1 _ |a Chirlaque, Maria-Dolores
|b 27
700 1 _ |a Rodríguez-Barranco, Miguel
|b 28
700 1 _ |a Barricarte, Aurelio
|b 29
700 1 _ |a Quirós, Jose Ramón
|b 30
700 1 _ |a Dorronsoro, Miren
|b 31
700 1 _ |a Johansson, Ingegerd
|b 32
700 1 _ |a Sund, Malin
|b 33
700 1 _ |a Sternby, Hanna
|b 34
700 1 _ |a Bradbury, Kathryn E
|0 0000-0003-3345-7333
|b 35
700 1 _ |a Wareham, Nick
|b 36
700 1 _ |a Riboli, Elio
|b 37
700 1 _ |a Gunter, Marc
|b 38
700 1 _ |a Brennan, Paul
|b 39
700 1 _ |a Duell, Eric J
|0 0000-0001-5256-0163
|b 40
700 1 _ |a Ferrari, Pietro
|b 41
773 _ _ |a 10.1002/ijc.31367
|g Vol. 143, no. 4, p. 801 - 812
|0 PERI:(DE-600)1474822-8
|n 4
|p 801 - 812
|t International journal of cancer
|v 143
|y 2018
|x 0020-7136
909 C O |o oai:inrepo02.dkfz.de:136770
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2015
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21